• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cullinan Therapeutics Inc (NQ: CGEM )

    15.58 -0.90 (-5.46%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Cullinan Therapeutics Inc

    < Previous 1 2 3 Next >
    Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
    Amgen reports mixed results from Phase 3 trials, with rocatinlimab showing moderate success in atopic dermatitis and Uplizna outperforming expectations in myasthenia gravis, offering less frequent... 
    Via Benzinga
    Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
    Merck has agreed to acquire CN201, a bispecific antibody from Curon Biopharmaceutical, for $700 million. This acquisition aims to advance Merck's pipeline for treating B-cell malignancies and... 
    Via Benzinga
    CGEM Stock Earnings: Cullinan Therapeutics Misses EPS for Q2 2024
    CGEM stock results show that Cullinan Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q1 2024
    CGEM stock results show that Cullinan Oncology beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Cullinan Oncology: Q4 Earnings Insights
    Via Benzinga
    Recap: Cullinan Oncology Q3 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?
    Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus... 
    Via Benzinga
    Analyst Ratings for Cullinan Oncology
    Via Benzinga
    Analyst Ratings for Cullinan Oncology
    Via Benzinga
    Analyst Expectations for Cullinan Oncology's Future
    Via Benzinga
    Expert Ratings for Cullinan Oncology
    Via Benzinga
    4 Analysts Have This to Say About Cullinan Oncology
    Via Benzinga
    Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. 
    Via Benzinga
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. 
    Via Benzinga
    Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
    Cullinan shifts focus to autoimmune diseases with CLN-978, targeting systemic lupus erythematosus. Initial trial results show potential for treatment with a differentiated safety profile. 
    Via Benzinga
    UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023
    CGEM stock results show that Cullinan Oncology beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Shares of Super Micro Computer, Inc. (NASDAQ: SMCI) shares rose sharply in today’s pre-market trading as the company posted upbeat results for its second quarter. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
    Via Benzinga
    Why Shares of Cullinan Oncology Jumped This Week
    The company's presentation at a conference got the attention of analysts and investors. 
    Via The Motley Fool
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.